The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis by Albillos, Agustín et al.
LIVER
The extent of the collateral circulation influences the
postprandial increase in portal pressure in patients with
cirrhosis
Agustı´n Albillos, Rafael Ban˜ares, Mo´nica Gonza´lez, Maria-Vega Catalina, Oscar Pastor, Rosario
Gonzalez, Cristina Ripoll, Jaime Bosch
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Professor A Albillos,
Departamento de Medicina,
Facultad de Medicina-
Campus Universitario,
Universidad de Alcala´,
Carretera Madrid-Barcelona
km 33.600, 28871 Alcala´
de Henares, Madrid, Spain;
aalbillosm@meditex.es
Revised 26 May 2006
Accepted 14 June 2006
Published Online First
12 July 2006
. . . . . . . . . . . . . . . . . . . . . . . .
Gut 2007;56:259–264. doi: 10.1136/gut.2006.095240
Background: In cirrhosis, repeated flares of portal pressure and collateral blood flow provoked by
postprandial hyperaemia may contribute to variceal dilation and rupture.
Aim: To examine the effect of the extent of the collateral circulation on the postprandial increase in portal
pressure observed in cirrhosis.
Patients and methods: The hepatic venous pressure gradient (HVPG), hepatic blood flow and azygos blood
flow were measured in 64 patients with cirrhosis before and after a standard liquid meal.
Results: Peak increases in HVPG (median+14.9%), hepatic blood flow (median+25.4%), and azygos blood
flow (median+32.2%) occurred at 30 min after the meal. Compared with patients with marked postprandial
increase in HVPG (above the median, n = 32), those showing mild (,15%, n = 32) increase in HVPG had a
higher baseline azygos flow (p,0.01) and underwent a greater postprandial increase in azygos flow
(p,0.02). Hepatic blood flow increased similarly in both groups. Postprandial increases in HVPG were
inversely correlated (p,0.001) with both baseline azygos flow (r =20.69) and its postprandial increase
(r =20.72). Food intake increased nitric oxide products in the azygos (p,0.01), but not in the hepatic vein.
Large varices (p,0.01) and previous variceal bleeding (p,0.001) were more frequent in patients with mild
increase in HVPG.
Conclusions: Postprandial hyperaemia simultaneously increases HVPG and collateral flow. The extent of the
collateral circulation determines the HVPG response to food intake. Patients with extensive collateralisation
show less pronounced postprandial increases in HVPG, but associated with marked flares in collateral flow.
Collateral vessels preserve their ability to dilate in response to increased blood flow.
S
planchnic vasodilatation and increased portal blood flow is
a physiological response to food intake.1 2 Experimental
studies have shown that endothelial cells lining the
sinusoids of the normal liver produce nitric oxide (NO) when
portal blood flow rises.3 In response to this rise in NO, the
hepatic microcirculation relaxes to accommodate the sudden
increase in blood flow, maintaining portal pressure as
normal.3 4 By contrast, the experimental or human cirrhotic
liver is unable to vasodilate when blood flow increases and
postprandial hyperaemia provokes an increase in portal
pressure.3–11 The inability of the cirrhotic liver to relax in
response to flow is partly due to an impaired capacity of the
sinusoidal cells to release NO.12 The postprandial rise in portal
pressure noted in cirrhosis varies greatly among individuals4–11
and the factors determining this variability remain unclear.
The portal-systemic collaterals, mainly oesophageal varices,
that develop in cirrhotic portal hypertension constitute an
attempt to decompress the portal venous system. Portal-
collateral and portal-hepatic vessel networks run a parallel
course, and their respective resistances are thought to
determine the portal pressure response to blood flow
increases,13 14 such as those occurring in the postprandial
period. Moreover, besides increasing portal blood flow,
splanchnic hyperaemia might also enhance collateral flow7 9 15
and thus contribute to the dilation and rupture of oesophageal
varices.16 The few studies examining the postprandial response
of portal-collateral blood flow in patients with cirrhosis
have yielded conflicting results.5 7 9 This study aimed to
establish whether the extent of the collateral circulation,
estimated as blood flow in the azygos vein, could influence
the postprandial increase in portal pressure that occurs in
patients with cirrhosis.
PATIENTS AND METHODS
Patients
The study population comprised 64 patients with cirrhosis and
oesophageal varices referred for evaluation of portal hyperten-
sion. Of these, 34 patients were studied at the Hospital Ramo´n y
Cajal, Madrid, Spain, and 30 at the Hospital Gregorio Maran˜o´n,
Madrid, Spain. Thirty six patients had previously undergone
variceal bleeding; 15 patients had mild–moderate ascites, 11
were receiving treatment with spironolactone and 4 with
spironolactone and furosemide. At the time of the study, no
patient had clinical evidence of hepatic encephalopathy. The
exclusion criteria were age ,18 years or .70 years, treatment
with b-blockers or band ligation for prophylaxis of variceal
bleeding, hepatocellular carcinoma, portal vein thrombosis or
advanced liver failure defined as bilirubin .5 mg/dl or
prothrombin time ,40%. The severity of liver disease was
graded according to Child–Pugh’s criteria. Oesophageal varices
.5 mm or ,5 mm were denoted large or small, respectively.17
The study protocol was approved by the ethics committees of
the participating centres. Patients participated after giving their
informed consent according to the Helsinki II Declaration.
Abbreviations: AzBF, azygos blood flow; HBF, hepatic blood flow; HVPG,
hepatic venous pressure gradient; ICG, indocyanine green; NOx, nitric
oxide metabolites
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Haemodynamic studies
After an overnight fast, two catheter introducers were placed in
the right femoral vein using the Seldinger technique. One of
these introducers was used to insert a balloon catheter (Medi-
Tech, Boston Scientific Cork, Cork, Ireland) into the right
hepatic vein to measure wedged and free hepatic vein pressures
or a Swan–Ganz catheter into the pulmonary artery to measure
cardiac output. The other vein introducer was used to advance a
continuous thermal dilution catheter (Webster Laboratories,
Baldwin Park, California, USA) into the azygos vein to measure
azygos blood flow (AzBF), according to previously described
methods.18–20 Measurements were performed in triplicate, and
permanent tracings were recorded on a multichannel recorder
(Hellige, Friburgo, Germany).
Portal pressure was estimated from the hepatic venous
pressure gradient (HVPG), as the difference between wedged
and free hepatic vein pressures. Heart rate and mean arterial
pressure were measured non-invasively every 10 min by an
automatic electronic sphygmomanometer (Dinamap; Critikon,
Tampa, Florida, USA). The cardiac index was obtained by
dividing cardiac output by body surface area. Hepatic blood
flow (HBF) was determined during continuous infusion of
indocyanine green (ICG, 0.2 mg/min; priming dose 5 mg; ICG;
Pulsion Medical Systems, Munich, Germany), as described
previously.19 20 Plasma concentrations of ICG were determined
by spectrophotometry using Nielsen’s method to correct for
plasma turbidity. Measurements were made in three separate
sets of simultaneous samples of peripheral and hepatic vein
blood obtained at 2-min intervals after an equilibration period
of 40 min. A hepatic extraction of ICG .0.1 was required to
calculate HBF. The systemic vascular resistance index (in
dyn s m2/cm5) was calculated as 806(mean arterial pressure–
right atrial pressure)/cardiac index.
Plasma glucagon immunoreactivity was analysed using a
commercially available radioimmunoassay kit (Double
Antibody Glucagon, DPC, Los Angeles, California, USA). The
detection limit of the assay was 13 ng/l, and the coefficient of
variation was 3.2–6.5% (Cayman, Ann Arbor, Michigan, USA).
Serum concentrations of NO metabolites (nitrates+nitrites
(nitric oxide metabolites (NOx))) were determined by chemi-
luminescence (Nitric Oxide Analyzer; NOA 280, Sievers
Instruments, Boulder, Colorado, USA).
Study design
At baseline, splanchnic (HVPG, HBF and AzBF) and systemic
haemodynamic variables (mean arterial pressure and cardiac
output) were determined in each patient. For the determination
of glucagon, blood samples were withdrawn from a peripheral
vein. For the determination of NOx, blood samples were drawn
from a hepatic vein, and in a subset of 29 patients from the
azygos vein. Thereafter, patients received a liquid meal
(400 ml) containing proteins (25 g), carbohydrates (80.8 g)
and lipids (19.6 g) to obtain a total of 600 kcal (Ensure Plus;
Abbott Laboratories BV, Zwolle, The Netherlands). The meal
was ingested in about 5 min. The onset of meal ingestion was
taken as time zero. Haemodynamic measurements and bio-
chemical determinations in blood were repeated at 15, 30 and
45 mins after meal ingestion.
Statistics
Results are expressed as mean (standard deviation (SD)
(range). Comparisons within patient groups were performed
by analysis of variance for repeated measures and Student’s t
test for paired data. Student’s t test for unpaired data was used
for comparisons among groups. Associations between contin-
uous variables were determined by linear regression analysis. A
value of p,0.05 was taken as significant. Multivariate analysis
by logistic regression was used to identify variables indepen-
dently associated with the postprandial increase in HVPG.
Variables were included in the analysis when they achieved a
p,0.05 in the univariate analysis. Statistical analysis was
performed using the StatView v5.0.1 package (Abacus
Concepts, Berkeley, California, USA).
RESULTS
The 64 patients examined had clinically significant portal
hypertension (range 12–22.6 mm Hg), and increased AzBF
(range 488–961 ml/min). The patients studied at the Hospital
Ramo´n y Cajal and Hospital Gregorio Maran˜o´n had similar
clinical characteristics (Child–Pugh score, 8.8 (1.0) v 8.9 (1.1);
oesophageal varices .5 mm, 65% v 60%; previous variceal
bleeding, 53% v 60%)) and baseline haemodynamic values
(HVPG, 19.1 (5.2) v 20.7 (6.6) mm Hg; AzBF, 617 (195) v 686
(184) ml/min).
HBF increased significantly 15 min after meal intake (from
992 (544) (range 834–1152) ml/min at baseline to 1152 (596)
(range 996–1323) ml/min, p,0.04) and peaked at 30 min
(1224 (648) (range 987–1437) ml/min; mean increase 22.8%
(23.2%); p,0.03; fig 1). Postprandial changes in HVPG
paralleled changes in HBF. HVPG increased significantly as
early as 15 min after meal intake (from 20.2 (4.0) (range 18.7–
21.9) mm Hg at baseline to 23.5 (4.2) (range 21.8–25.2) mm
Hg), peaked at 30 min (23.9 (5.6) (range 21.5–26.1) mm Hg;
absolute change 3.9 (4.0) mm Hg), and remained increased at
45 min (23.3 (6.4) (range 21.7–26.1) mm Hg, all p,0.001 v
baseline). AzBF was also significantly increased at 15 min
(from 654 (336) (range 560–757) ml/min at baseline to 795
(408) (range 683–927) ml/min, p,0.03 v baseline) and peaked
at 30 min (834 (528) (range 694–985) ml/min, p,0.02).
However, by 45 min after meal intake, AzBF was not
significantly different from baseline (717 (352) (range 611–
827) ml/min, p = 0.3). As HBF, HVPG and AzBF peaked at
30 min after food intake, in subsequent analysis, we focused on
the 30-min time point.
The mean (SD) change in HVPG 30 min after the meal was
17.9% (14.4%) (range 0–52%). We then divided the patient
population according to the median postprandial (30 min)
increase in HVPG (14.9%) into two groups: one comprised 32
patients showing ‘‘mild’’ (below the median) postprandial
increase in HVPG (mean (SD) increase 1.8 (0.5) mm Hg, 6.1%
(5.0%)) and another group comprised 32 patients showing
‘‘marked’’ (.15%) postprandial increase in HVPG (5.9
(2.2) mm Hg, 28.7% (10.3%); fig 2).
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Figure 1 Changes in the hepatic venous pressure gradient (HVPG),
hepatic blood flow (HBF) and azygos blood flow (AzBF) estimated 15, 30
and 45 min after food intake. Data represent percentage changes from
baseline (mean (SD)). Asterisks indicate a significant difference from
baseline (*p,0.05, **p,0.001), and crosses indicate significant
differences from the change at 15 min (*p,0.05).
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Our two patient groups were well-matched in terms of the
aetiology and severity of liver disease, as assessed by Child–
Pugh score and the presence of ascites (table 1). In addition,
both groups had similar baseline HVPG and HBF values.
Extents of systemic hyperaemia and peripheral vasodilatation,
as assessed by cardiac index and systemic vascular resistance
values, were also comparable in the two groups of patients.
However, the group with mild increase in postprandial HVPG
showed greater baseline values of collateral blood flow, as
measured by AzBF (739 (316) (range 614–876) v 561 (186)
(range 452–661) ml/min, p,0.01) than the group with marked
increase in postprandial HVPG. Accordingly, the patients with
mild increase in postprandial HVPG showed a significantly
higher prevalence of large oesophageal varices and previous
variceal bleeding (table 1).
At 30 min, the test meal induced similar increases in HBF
(22.1 (32.2) v 23.0 (28.6) %, p = 0.98) and serum glucagon
concentrations (28.1 (45) v 28.6% (51%), p = 0.96) in patients
with mild and marked postprandial increase in HVPG (table 1).
Despite this similar HBF response to the meal in both groups,
the postprandial increase in AzBF was significantly greater in
patients showing mild compared with marked increase in
HVPG (35.7% (34%) v 17.1% (23%), p,0.01; fig 2). For the
entire patient set, postprandial increase in HVPG was inversely
related to the extent of portal-collateral circulation, as assessed
by AzBF, both in terms of baseline values (r =20.69, p,0.001)
and postprandial increases (r =20.72, p,0.001; fig 3). AzBF
showed a marked increase in all 10 patients in whom HVPG
failed to change 30 min after food intake (mean (SD) change
56.6% (28.3%); range 45.2–64.3%).
Postprandial hyperaemia caused a significant increase in
serum concentrations of NOx in the azygos vein in both patient
groups (table 2). By contrast, the postprandial increase in HBF
did not significantly modify NOx levels in the hepatic vein of
either group.
DISCUSSION
In this study, we sought to assess whether the extent of the
portal-collateral circulation, as estimated by AzBF, could affect
the portal pressure response to food intake in patients with
cirrhosis. We hypothesised that patients with extensive devel-
opment of portal-systemic collaterals would be able to
accommodate the large increase in blood flow caused by
postprandial hyperaemia without markedly increasing the
perfusion pressure (ie, the portal pressure). By contrast, we
predicted that patients with mild collateralisation would show
a marked increase in portal pressure, because of the known
impaired capacity of the cirrhotic liver to undergo flow-
mediated vasodilatation due to intrahepatic endothelial dys-
function.3 12 To test this working hypothesis, we compared basal
and postprandial AzBF in a cohort of patients with cirrhosis
showing marked or mild postprandial increases in portal
pressure, as estimated by HVPG measurement.
Our findings indicate that the splanchnic hyperaemia that
follows meal ingestion in patients with cirrhosis leads to
increases in both portal pressure and portal-collateral blood
flow (collateral hyperaemia). As in other vascular beds, the
endothelial cells of the hepatic sinusoids augment NO produc-
tion in response to shear stress, which allows the normal liver
to accommodate increases in portal blood flow.3 4 Confirming
previous experimental and clinical studies,4 8 11 21 the livers of
our patients with cirrhosis failed to show a vasodilatory NO-
mediated adaptive response to postprandial hyperaemia, as
indicated by the increases recorded in portal pressure after the
test meal and the lack of changes in NOx levels observed in the
hepatic vein.
Besides increasing portal pressure, postprandial hyperaemia
led to pronounced increases in collateral blood flow. The
finding of a marked increase in AzBF in the group of patients
with mild increase in HVPG indicates that collateral resistance
decreases in response to blood flow load after food intake. In
addition, hyperaemia was associated with a selective increase in
serum NOx in the azygos vein, suggesting flow-induced up
regulation of endothelial NO production in the collaterals.
Thus, contrary to the situation in the hepatic circulation, flow-
dependent relaxation is preserved in portal-collateral vessels in
cirrhosis. This finding has not been previously reported in
patients with cirrhosis. In effect, in situ collateral perfusion
experiments have shown that the portal-collateral vessels dilate
in response to isoproterenol, a b-adrenoceptor, or acetylcholine,
a NO agonist, and contract in response to endothelin-1 and
vasopressin.22–24 We postulate that the shear stress caused by
postprandial hyperaemia promotes NO release and relaxation at
the level of the collateral vessels.
The degree of postprandial hyperaemia is influenced by the
type of meal and host characteristics. The timing and intensity
of hyperaemia have been related to the caloric content and
composition of the meal, with carbohydrates inducing the
earliest and fat the greatest intestinal blood-flow response.1 All
our patients received the same meal containing similar
proportions of proteins, fats and carbohydrates as those of a
standard diet. Variations in the response shown by patients
with cirrhosis to such a meal include a lesser degree of
postprandial splanchnic hyperaemia in those with alcoholic
disease, advanced (Child C) cirrhosis or severe peripheral
vasodilatation and hyperdynamic circulation.7 25 26 None of
these factors was, however, able to predict the postprandial
increase in HVPG shown by our patients.
The only difference we found between patients with marked
or mild postprandial increase in HVPG was related to the extent
of collaterals. In keeping with our hypothesis, patients with
extensive portal-collateral circulation, high AzBF, large varices
and previous variceal bleeding showed a less pronounced
postprandial increase in portal pressure despite exhibiting
marked increases in collateral blood flow. Greatest increases
in portal pressure were noted in patients with mild collater-
alisation, suggesting that the extent of the portal-collateral
circulation largely determines the portal pressure response to
food intake. This idea is further supported by the inverse
correlation shown between postprandial changes in HVPG and
AzBF, whether we considered baseline or postprandial changes
in AzBF. Moreover, these results were reinforced by our logistic
regression analysis, which indicated that baseline AzBF and
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Figure 2 Postprandial (30 min) changes in the hepatic venous pressure
gradient (HVPG) and azygos blood flow. The median (14.9%) postprandial
change in the HVPG was used to divide the 64 patients with cirrhosis into
those with mild (n = 32; white boxes) or marked (n = 32; grey boxes)
postprandial increase in HVPG. The box plots represents the 10th, 25th,
50th (median), 75th and 90th centiles of the variables.
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postprandial changes in AzBF were independently associated
with the postprandial change in HVPG. In cirrhosis, portal
blood flows through two parallel vascular networks: the liver
sinusoids and the portal-collateral vessels, the second network
including the oesophageal varices. The resistance posed by the
collateral vessels to portal flow is greater than that of the
normal hepatic microcirculation, but lower than the resistance
offered by the sinusoids of the cirrhotic liver.13 In consequence,
the different resistance shown by each of these vascular
networks to portal flow influences portal pressure.
Several practical and pathophysiological implications can be
drawn from our results. Considerable attention has been
devoted in recent years to develop drugs (ie, vasodilators) that
lower portal pressure by modulating the dynamic component of
the increased vascular resistance of the cirrhotic liver.4 11 21 27
These studies have taken advantage of the portal pressure
response to meal ingestion to test the adaptive vasodilatory
efficiency of the intrahepatic circulation. The results of this
study indicate that the postprandial increase in portal pressure
in patients with cirrhosis is determined not only by intrahepatic
vascular resistance but also by the extent of portal venous
system collateralisation. We propose that future studies in
which postprandial hyperaemia is used to test the dynamic
component of intrahepatic vascular resistance should stratify
Table 1 Basal and postprandial (30 min after meal intake) clinical, haemodynamic and biochemical variables in the groups of
patients showing mild or marked increase in postprandial hepatic venous pressure gradient
Mild increase in
HPVG (n = 32)
Marked increase in
HPVG (n = 32) p Values
Clinical data
Age (years) 55 (22) (44–66) 58 (23) (46–68) NS
Sex (males/females) 26/6 28/4 NS
Aetiology of cirrhosis (alcoholics/non-alcoholics) 18/14 19/13 NS
Child–Pugh score 9.1 (1.1) (7–10) 8.8 (1.1) (6–10) NS
Body weight (kg) 66 (28) (52–78) 65 (22) (53–76) NS
Ascites (%) 8/24 7/25 NS
Oesophageal varices .5 mm (yes/no) 26/6 14/18 ,0.01
Previous variceal bleeding (yes/no) 28/4 8/24 ,0.0001
Splanchnic haemodynamics
Baseline HVPG (mm Hg) 20.4 (6.7) (15.1–24.2) 19.8 (6.2) (22.2–29.7) NS
Postprandial HVPG (mm Hg) 21.8 (5.1) (18.3–25.6)* 25.5 (5.1) (18.3–25.6)**
Postprandial change in HVPG (%) 6.1 (5.0) (3.6–8.4) 28.7 (10.2) (24.0–33.5)
Baseline HBF (ml/min) 986 (320) (853–1122) 1006 (401) (843–1215) NS
Postprandial HBF (ml/min) 1203 (446) (962–1419)*** 1234 (487) (985–1427)*** NS
Postprandial change in HBF (%) 22.1 (21) (9.4–34.7) 23.0 (20) (11.3–35.1) NS
Baseline AzBF (ml/min) 739 (316) (614–876) 561 (186) (452–661) ,0.01
Postprandial AzBF (ml/min) 980 (429) (804–1182)*** 659 (237) (543–769)* ,0.001
Postprandial change in AzBF (%) 35.7 (28) (23.1–48.2) 17.1 (16) (8.2–26.6) ,0.01
Systemic haemodynamics
Baseline mean arterial pressure (mm Hg) 82 (16) (62–90) 84 (16) (75–91) NS
Postprandial mean arterial pressure (mm Hg) 80 (22) (range 70–89) 81 (17) (range 72–88) NS
Postprandial change in mean arterial pressure (%) 2.4 (1.1) (1.8–2.9) 3.5 (1.1) (2.6–4.1) NS
Baseline cardiac index (l/min m2) 4.32 (1.7) (3.5–5.0) 4.24 (1.7) (3.4–4.9) NS
Postprandial cardiac index (l/min m2) 4.66 (2.2)
(3.7–5.7)
4.55 (2.2) (3.6–5.4) NS
Postprandial change in cardiac index (%) 8.1 (3.3) (6.5–9.9) 7.8 (2.8) (6.5–9.2) NS
Baseline systemic vascular resistance (dyne s m2/cm5) 1527 (526) (1321–1784) 1604 (605) (1344–1876) NS
Postprandial systemic vascular resistance (dyne s m2/cm5) 1386 (418) (1202–1594)* 1410 (459) (1217–1609)* NS
Postprandial change in systemic vascular resistance (dyne s m2/cm5) 9.3 (4.5) (7.4–11.8) 11.6 (5.6) (9.2–14.1) NS
Biochemical data
Baseline serum glucagon (ng/l) 93 (49) (72–112) 91 (53) (69–121) NS
Postprandial serum glucagon (ng/l) 121 (67) (94–153)*** 117 (62) (89–141)*** NS
Postprandial change in serum glucagon (%) 28.1 (45) (11.2–44.4) 28.6 (51) (10.1–46.9) NS
AzBF, azygous blood flow; HBF, hepatic blood flow; HVPG, hepatic venous pressure gradient.
Values are mean (SD) (range).
*p,0.05, **p,0.001 and ***p,0.01 v baseline.
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patients according to their degree of portal-systemic collater-
alisation. As measurement of AzBF by thermodilution is not yet
available in most centres, stratification could be based on
surrogate variables, such as variceal size and a history of
variceal bleeding. Both these factors were found to be related to
the magnitude of the postprandial increase in HVPG in our
study. Indeed, variceal size and previous variceal bleeding
showed accuracies of 69% and 81%, respectively, for classifying
the patients by extent of portal-systemic collateralisation.
Our study has several limitations. Firstly, we evaluated
changes in the intrahepatic circulation in response to food
intake by the combined measurement of HVPG, to estimate
portal pressure, and fractional clearance of ICG, to estimate
HBF. The latter evaluates the sum of arterial and portal hepatic
blood flow. Thus, the possibility exists that after a meal, portal
and total hepatic blood flow could behave differently. In such a
case, HBF measured by the ICG constant infusion technique
would underestimate the postprandial increase in portal inflow.
Nevertheless, using this technique, we were able to detect a
significant increase in HBF of similar magnitude in patients
with mild or marked postprandial increases in HVPG. Secondly,
to investigate the factors underlying the great variability of the
portal pressure response to meal ingestion, we divided our
patients into two groups according to the extent of the
postprandial rise in HVPG. The 15% discriminating value
selected was based on the following criteria:
N this number is the median of the distribution of the
postprandial change in HVPG;
N a variation of at least 10% is considered a measurable change
in HVPG18 28 29; and
N a longitudinal study has shown the prognostic value of a
15% change in HVPG in patients with alcoholic cirrhosis.30
Taken together, our results implicate postprandial increases
in portal pressure and collateral flow in the pathophysiology of
the variceal enlargement that precedes variceal bleeding and
predisposes the patient to this complication. In the early stages
of portal hypertension, when the portal-collateral system is not
yet fully developed, postprandial hyperaemia leads to pro-
nounced increases in HVPG. Hence, repeated postprandial
flares in portal pressure could promote the opening and growth
of collaterals. Recent experimental studies have shown that
increased portal pressure activates vascular endothelial growth
factor expression,31 which might promote new vessel forma-
tion.32 In advanced stages, when portal-systemic collateralisa-
tion is extensive, the resistance of the collateral vessels becomes
an important determining factor for overall portal resistance. In
consequence, postprandial hyperaemia results in less pro-
nounced increases in HVPG, but in marked increases in
collateral blood flow (collateral hyperaemia). Hyperaemia-
driven shear stress stimulates vascular endothelial growth
factor and NO production by the endothelium of the collateral
vessels, which enhances portal-collateral development and
distension independently of portal pressure.23 31 At this stage,
the measurement of portal pressure changes might under-
estimate the potential effect of postprandial hyperaemia on
variceal dilation. This situation is the opposite of the response
to propranolol, in which the reduction in HVPG and AzBF
caused by the drug results in a decrease in the transmural
pressure, radius and wall tension of the varix.33 In a patient
with large oesophageal varices, the postprandial increase in
HVPG is blunted, but associated with intense collateral flow,
possibly aggravating variceal distension, thus leading to
variceal enlargement and an increased risk of bleeding.
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